Drug and vaccine authorizations for COVID-19: List of authorized drugs and expanded indications

Date published: 2020-11-20

Drugs that have been authorized by Health Canada for use in relation to the COVID-19 pandemic are listed here.

In the list below, the entry for each authorized drug includes the:

In the "authorization" column, there are 4 possible scenarios:

List of authorized drugs and expanded indications for COVID-19
Authorization holder Brand name, proper name or common name DIN, medicinal ingredient(s), strength, dosage form, route of administration Therapeutic area Control number Date of authorization or expanded indication Authorization or expanded indication
Gilead Sciences Canada Inc. Veklury
Remdesivir solution for injection

DIN 02502135 - 100 mg/20 mL remdesivir, solution, intravenous administration

DIN 02502143 - 100 mg/vial remdesivir, powder for solution, intravenous administration

Antivirals for systemic use, for human use 240551 2020-07-27 Food and Drug Regulations. Issued Notice of Compliance under the NOC/c Guidance.
Eli Lilly Canada Inc Bamlanivimab
Bamlanivimab solution for injection
DIN 02508176 - 700 mg/20 mL bamlanivimab, solution, intravenous administration Immune sera and immunoglobulins, for human use 244947 2020-11-20 Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19. Authorized with terms and conditions.
Report a problem or mistake on this page
Please select all that apply:

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: